Do analysts prefer INBS or TMDIF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend INBS or CODX?

Co-Diagnostics has a consensus price target of $67.50, suggesting a potential upside of 1,283.20%. Given Co-Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Co-Diagnostics is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Co-Diagnostics 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate FEMY or INBS?

Femasys currently has a consensus target price of $106.67, indicating a potential upside of 2,155.11%. Given Femasys' stronger consensus rating and higher possible upside, research analysts plainly believe Femasys is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Intelligent Bio Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to FEMY or INBS?

In the previous week, Femasys had 3 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 6 mentions for Femasys and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.97 beat Femasys' score of 0.13 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Femasys 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Intelligent Bio Solutions 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer INBS or LFWD?

Lifeward has a consensus price target of $10.00, indicating a potential upside of 41.44%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lifeward 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Does the media refer more to INBS or LFWD?

In the previous week, Lifeward had 7 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 10 mentions for Lifeward and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.97 beat Lifeward's score of 0.04 indicating that Intelligent Bio Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intelligent Bio Solutions 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifeward 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer INBS or RVP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Intelligent Bio Solutions (INBS) Competitors

$2.35 -0.07 (-2.89%)

Closing price 06/10/2026 04:00 PM Eastern

Extended Trading

$2.36 +0.00 (+0.21%)

As of 06/10/2026 07:28 PM Eastern

Compare

INBS vs. TMDIF, CODX, FEMY, LFWD, and RVP

Should you buy Intelligent Bio Solutions stock or one of its competitors? MarketBeat compares Intelligent Bio Solutions with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Intelligent Bio Solutions include Titan Medical (TMDIF), Co-Diagnostics (CODX), Femasys (FEMY), Lifeward (LFWD), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry.

How does Intelligent Bio Solutions compare to Titan Medical?

Intelligent Bio Solutions (NASDAQ:INBS) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Intelligent Bio Solutions had 3 more articles in the media than Titan Medical. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 0 mentions for Titan Medical. Intelligent Bio Solutions' average media sentiment score of 0.97 beat Titan Medical's score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Intelligent Bio Solutions	Positive
Titan Medical	Neutral

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Titan Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -296.73%. Titan Medical's return on equity of -82.31% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Titan Medical	N/A	-82.31%	-51.47%

Titan Medical has higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05M	1.84	-$10.57M	-$12.22	N/A
Titan Medical	$17.63M	1.09	$6.95M	$0.05	3.37

Intelligent Bio Solutions has a beta of 4.21, meaning that its share price is 321% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Summary

Intelligent Bio Solutions and Titan Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Co-Diagnostics?

Intelligent Bio Solutions (NASDAQ:INBS) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

Co-Diagnostics has a consensus price target of $67.50, suggesting a potential upside of 1,283.20%. Given Co-Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Co-Diagnostics is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Co-Diagnostics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 5.4% of Co-Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Intelligent Bio Solutions has higher revenue and earnings than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05M	1.84	-$10.57M	-$12.22	N/A
Co-Diagnostics	$620K	29.04	-$46.90M	-$15.77	N/A

Intelligent Bio Solutions has a beta of 4.21, suggesting that its share price is 321% more volatile than the broader market. Comparatively, Co-Diagnostics has a beta of 2.74, suggesting that its share price is 174% more volatile than the broader market.

In the previous week, Intelligent Bio Solutions had 1 more articles in the media than Co-Diagnostics. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 2 mentions for Co-Diagnostics. Intelligent Bio Solutions' average media sentiment score of 0.97 beat Co-Diagnostics' score of 0.44 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Intelligent Bio Solutions	Positive
Co-Diagnostics	Neutral

Intelligent Bio Solutions has a net margin of -296.73% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Co-Diagnostics	-6,760.63%	-164.92%	-141.15%

Summary

Intelligent Bio Solutions beats Co-Diagnostics on 10 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Femasys?

Femasys (NASDAQ:FEMY) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

In the previous week, Femasys had 3 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 6 mentions for Femasys and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.97 beat Femasys' score of 0.13 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Femasys	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Intelligent Bio Solutions	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

65.3% of Femasys shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 7.6% of Femasys shares are owned by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Femasys currently has a consensus target price of $106.67, indicating a potential upside of 2,155.11%. Given Femasys' stronger consensus rating and higher possible upside, research analysts plainly believe Femasys is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Intelligent Bio Solutions has a net margin of -296.73% compared to Femasys' net margin of -521.97%. Intelligent Bio Solutions' return on equity of -176.09% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

Intelligent Bio Solutions has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	6.24	-$18.63M	-$0.27	N/A
Intelligent Bio Solutions	$3.05M	1.84	-$10.57M	-$12.22	N/A

Femasys has a beta of -2.23, suggesting that its share price is 323% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.21, suggesting that its share price is 321% more volatile than the broader market.

Summary

Femasys beats Intelligent Bio Solutions on 9 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Lifeward?

Intelligent Bio Solutions (NASDAQ:INBS) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, Lifeward had 7 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 10 mentions for Lifeward and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.97 beat Lifeward's score of 0.04 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intelligent Bio Solutions	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lifeward	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Lifeward has a consensus price target of $10.00, indicating a potential upside of 41.44%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Intelligent Bio Solutions has higher earnings, but lower revenue than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05M	1.84	-$10.57M	-$12.22	N/A
Lifeward	$20.92M	0.95	-$19.91M	-$19.66	N/A

Lifeward has a net margin of -123.66% compared to Intelligent Bio Solutions' net margin of -296.73%. Intelligent Bio Solutions' return on equity of -176.09% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Lifeward	-123.66%	-243.14%	-97.39%

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 1.5% of Lifeward shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Intelligent Bio Solutions has a beta of 4.21, meaning that its share price is 321% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, meaning that its share price is 64% less volatile than the broader market.

Summary

Intelligent Bio Solutions beats Lifeward on 9 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Retractable Technologies?

Intelligent Bio Solutions (NASDAQ:INBS) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

Retractable Technologies has higher revenue and earnings than Intelligent Bio Solutions. Retractable Technologies is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05M	1.84	-$10.57M	-$12.22	N/A
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Intelligent Bio Solutions had 3 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 0 mentions for Retractable Technologies. Intelligent Bio Solutions' average media sentiment score of 0.97 beat Retractable Technologies' score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Intelligent Bio Solutions	Positive
Retractable Technologies	Neutral

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Intelligent Bio Solutions has a beta of 4.21, meaning that its stock price is 321% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

Retractable Technologies has a net margin of -41.11% compared to Intelligent Bio Solutions' net margin of -296.73%. Retractable Technologies' return on equity of -17.15% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Summary

Intelligent Bio Solutions and Retractable Technologies tied by winning 7 of the 14 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INBS vs. The Competition

Export

Metric	Intelligent Bio Solutions	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.79M	$8.99B	$6.50B	$11.95B
Dividend Yield	N/A	1.74%	2.67%	5.61%
P/E Ratio	-0.19	24.39	24.41	23.63
Price / Sales	1.84	18.40	500.91	102.25
Price / Cash	N/A	90.88	43.05	54.72
Price / Book	0.58	5.45	10.43	6.70
Net Income	-$10.57M	$179.69M	$3.56B	$337.26M
7 Day Performance	-4.47%	-1.52%	-2.94%	-2.43%
1 Month Performance	-25.16%	7.26%	-0.39%	0.19%
1 Year Performance	-88.13%	0.31%	20.10%	23.15%

Intelligent Bio Solutions Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INBS Intelligent Bio Solutions	1.1418 of 5 stars	$2.35 -2.9%	N/A	-87.2%	$5.79M	$3.05M	N/A	10	Short Interest Decrease
TMDIF Titan Medical	N/A	$0.21 +11.3%	N/A	-34.1%	$23.48M	$17.63M	N/A	50
CODX Co-Diagnostics	2.0418 of 5 stars	$6.22 +0.3%	$67.50 +985.2%	-44.2%	$22.85M	$620K	N/A	100	Short Interest Increase Gap Down
FEMY Femasys	2.023 of 5 stars	$0.37 -1.7%	$5.33 +1,336.4%	-70.4%	$22.82M	$2.29M	N/A	30	Stock Split Short Interest Increase
LFWD Lifeward	2.7381 of 5 stars	$7.68 -3.4%	$10.00 +30.2%	-51.7%	$22.38M	$22.03M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INBS) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intelligent Bio Solutions (INBS) Competitors

INBS vs. TMDIF, CODX, FEMY, LFWD, and RVP

How does Intelligent Bio Solutions compare to Titan Medical?

Summary

How does Intelligent Bio Solutions compare to Co-Diagnostics?

Summary

How does Intelligent Bio Solutions compare to Femasys?

Summary

How does Intelligent Bio Solutions compare to Lifeward?

Summary

How does Intelligent Bio Solutions compare to Retractable Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intelligent Bio Solutions (INBS) Competitors

INBS vs. TMDIF, CODX, FEMY, LFWD, and RVP

How does Intelligent Bio Solutions compare to Titan Medical?

Do analysts prefer INBS or TMDIF?

Does the media refer more to INBS or TMDIF?

Do insiders and institutionals hold more shares of INBS or TMDIF?

Is INBS or TMDIF more profitable?

Which has higher earnings & valuation, INBS or TMDIF?

Which has more risk & volatility, INBS or TMDIF?

Summary

How does Intelligent Bio Solutions compare to Co-Diagnostics?

Do analysts recommend INBS or CODX?

Do insiders & institutionals have more ownership in INBS or CODX?

Which has better valuation and earnings, INBS or CODX?

Which has more risk & volatility, INBS or CODX?

Does the media favor INBS or CODX?

Is INBS or CODX more profitable?

Summary

How does Intelligent Bio Solutions compare to Femasys?

Does the media refer more to FEMY or INBS?

Do insiders and institutionals believe in FEMY or INBS?

Do analysts rate FEMY or INBS?

Is FEMY or INBS more profitable?

Which has preferable valuation & earnings, FEMY or INBS?

Which has more volatility and risk, FEMY or INBS?

Summary

How does Intelligent Bio Solutions compare to Lifeward?

Does the media refer more to INBS or LFWD?

Do analysts prefer INBS or LFWD?

Which has better valuation & earnings, INBS or LFWD?

Is INBS or LFWD more profitable?

Do insiders & institutionals believe in INBS or LFWD?

Which has more risk and volatility, INBS or LFWD?

Summary

How does Intelligent Bio Solutions compare to Retractable Technologies?

Which has preferable valuation & earnings, INBS or RVP?

Do analysts prefer INBS or RVP?

Does the media prefer INBS or RVP?

Do insiders and institutionals have more ownership in INBS or RVP?

Which has more risk & volatility, INBS or RVP?

Is INBS or RVP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools